Cytosorbents Corporation (CTSO)

Cytosorbents Stock Forecast

Stock Price Forecast

According to 2 professional analysts, the 12-month price target for Cytosorbents stock ranges from a low of $1.00 to a high of $10. The average analyst price target of $5.50 forecasts a 409.26% increase in the stock price over the next year.

Price Target: $5.50 (+409.26%)

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$1.00	$5.50	$10	$10
Change	-7.41%	+409.26%	+825.93%	+825.93%

Analyst Ratings

The average analyst rating for Cytosorbents stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Mar '25	Apr '25	May '25	Jun '25	Jul '25	Aug '25
Strong Buy	2	2	2	1	1	1
Buy	0	0	0	0	0	0
Hold	1	1	1	1	1	1
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	3	3	3	2	2	2

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Jason Kolbert D. Boral Capital	D. Boral Capital	Strong Buy Maintains $10	Strong Buy	Maintains	$10	+825.93%	Aug 8, 2025
Jason Kolbert D. Boral Capital	D. Boral Capital	Strong Buy Maintains $10	Strong Buy	Maintains	$10	+825.93%	Jul 21, 2025
Jason Kolbert D. Boral Capital	D. Boral Capital	Strong Buy Maintains $10	Strong Buy	Maintains	$10	+825.93%	Jun 25, 2025
Jason Kolbert D. Boral Capital	D. Boral Capital	Strong Buy Maintains $10	Strong Buy	Maintains	$10	+825.93%	May 15, 2025
Sean Lee HC Wainwright & Co.	HC Wainwright & Co.	Hold Reiterates $1	Hold	Reiterates	$1	-7.41%	May 15, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

39.56M

Increased by 11.15%

from 35.59M

Revenue Next Year

48.02M

Increased by 21.39%

from 39.56M

EPS This Year

-0.16

from -0.38

EPS Next Year

-0.09

from -0.16

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	41.00M	43.17M	34.69M	31.08M	35.59M	39.56M	48.02M	62.83M
Revenue Growth	64.35%	5.27%	-19.64%	-10.39%	14.51%	11.15%	21.39%	30.84%
EPS	-0.20	-0.57	-0.75	-0.65	-0.38	-0.16	-0.09	0.04
EPS Growth	-	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-	30.25
No. Analysts	-	-	-	-	-	5	5	4

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027	2028	2029
High	41.8M	55.9M	74.6M
Avg	39.6M	48.0M	62.8M
Low	36.3M	40.9M	51.1M

Revenue Growth

Revenue Growth	2025	2026	2027	2028	2029
High	17.5%	41.4%	55.3%
Avg	11.1%	21.4%	30.8%
Low	1.9%	3.3%	6.4%

EPS Forecast

EPS	2025	2026	2027
High	-0.07	0.05	0.22
Avg	-0.16	-0.09	0.04
Low	-0.21	-0.20	-0.14

EPS Growth

EPS Growth	2025	2026	2027
High	-	-	-
Avg	-	-	-
Low	-	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.